Skystone Atlas, LLC — Strategic Consulting
Turning insight into forward momentum. Advisory at the intersection of healthcare, dental, and life sciences — where bold ideas move faster, strategy lands with precision, and meaningful progress becomes the outcome.
Specialized advisory across two of the most complex and regulated sectors in business — unified by a single, precision-driven methodology.
Thirteen years spanning biotech research, clinical practice, life sciences, and startup operations — across cardiology, neuroscience, bioengineering, and dental research.
Skystone Atlas is led by a principal advisor with a rare dual background spanning scientific research and clinical practice, supported by a network of advisors and collaborators across both practice areas.
Great science and great clinical work deserve a business foundation that matches them. Building that foundation is where Skystone Atlas begins.
Each engagement draws on thirteen years of firsthand work across biotech research, clinical practice, life sciences, and startup operations. That experience is sharpened by a Rice University MBA and MS. The work brings both worlds to the table, holds both sets of pressures in view, and carries a firsthand sense of what it takes to move forward.
That breadth produces something rare: a strategic advisor who sees clinical realities and business pressures at the same time, not in sequence. The result is advisory that moves faster, lands closer to the truth, and builds toward outcomes that actually hold.
▸ Connect on LinkedInScience that moves forward requires more than a strong hypothesis. It requires people who understand what the data actually means and what it will take to carry it past the next decision point.
Fourteen years across neuroscience, psychology, pharmacology, cardiology, and gastroenterology produced something beyond domain expertise. The work moved through academic research, peer-reviewed publication, drug development, and biotech startup operations, building a longitudinal view of how programs are built, where they break, and what it actually takes to innovate them.
What that depth produces is an advisor who brings scientific rigor and strategic precision to the same problem simultaneously, not as complementary skills but as a single integrated lens.
▸ Connect on LinkedInAdvisors & Collaborators — Skystone Atlas is supported by a network of advisors and collaborators with expertise across clinical research, regulatory affairs, dental operations, and life sciences — extending our capabilities across both practice areas.
Bold ideas deserve the infrastructure to move faster. Whether you lead a dental practice or a life sciences organization — let’s build something that lasts.
Comprehensive advisory for dental groups and healthcare operators navigating growth, performance optimization, and strategic planning. Clinical context drives every business decision we make.
Most dental consultants have never worked chairside. We have. That changes how we diagnose problems, structure solutions, and build recommendations that actually work in a clinical environment.
Skystone Atlas dental and healthcare advisory is designed for a range of practice types and growth stages.
Growth-oriented practices looking to optimize performance, identify revenue opportunities, and build the operational foundation for expansion.
Dental groups navigating multi-site operations, provider alignment, and the organizational complexity that comes with scale.
Owners evaluating strategic options — whether that means partnership, acquisition, or positioning for the next phase of growth.
Healthcare organizations seeking a clinical-first advisory perspective on operations, performance, and strategic planning.
Most dental practices are closer to their next level of performance than they think. The gap is almost always strategic, not clinical.
Let’s build a strategy that translates clinical excellence into measurable business outcomes.
Strategic advisory for biotech startups, research-stage companies, and life sciences organizations at critical inflection points — from early-stage operations through key milestones and investor readiness.
A background in biotech research spanning cardiology, neuroscience, dental research, and bioengineering means understanding the science and the commercial pressures simultaneously — not in sequence.
Skystone Atlas life sciences advisory is designed for organizations across the development and commercialization spectrum.
Companies in the formation or seed stage building the operational and strategic foundation needed to execute on their science and attract investment.
Academic spinouts and research organizations transitioning from scientific development toward commercialization, partnership, or licensing strategy.
Organizations at key inflection points — approaching milestone readouts, preparing for financing rounds, or planning commercial launch.
Investors and boards seeking an independent strategic perspective on portfolio companies across biotech, med-tech, and life sciences sectors.
The most common challenge in life sciences isn’t the science. It’s building the strategic infrastructure to carry it forward.
We bring the strategic clarity that turns scientific progress into business momentum.
Skystone Atlas is led by a principal advisor with a rare dual background spanning scientific research and clinical practice, supported by a network of advisors and collaborators across both practice areas.
Each engagement at Skystone Atlas draws on a combination of clinical fluency, scientific rigor, and business strategy. Below are the leaders carrying that work forward.
Great science and great clinical work deserve a business foundation that matches them. Building that foundation is where Skystone Atlas begins.
Each engagement draws on thirteen years of firsthand work across biotech research, clinical practice, life sciences, and startup operations. That experience is sharpened by a Rice University MBA and MS. The work brings both worlds to the table, holds both sets of pressures in view, and carries a firsthand sense of what it takes to move forward.
That breadth produces something rare: a strategic advisor who sees clinical realities and business pressures at the same time, not in sequence. The result is advisory that moves faster, lands closer to the truth, and builds toward outcomes that actually hold.
▸ Connect on LinkedInScience that moves forward requires more than a strong hypothesis. It requires people who understand what the data actually means and what it will take to carry it past the next decision point.
Fourteen years across neuroscience, psychology, pharmacology, cardiology, and gastroenterology produced something beyond domain expertise. The work moved through academic research, peer-reviewed publication, drug development, and biotech startup operations, building a longitudinal view of how programs are built, where they break, and what it actually takes to innovate them.
What that depth produces is an advisor who brings scientific rigor and strategic precision to the same problem simultaneously, not as complementary skills but as a single integrated lens.
▸ Connect on LinkedInAdvisors & Collaborators — Skystone Atlas is supported by a network of advisors and collaborators with expertise across clinical research, regulatory affairs, dental operations, and life sciences — extending our capabilities across both practice areas.
Whether you’re a dental group, a biotech founder, or a life sciences leader at an inflection point, we’d like to hear what you’re working on.
Strategic insights and frameworks from the intersection of clinical expertise and business strategy. Practical intelligence for healthcare and life sciences leaders.
Atlas Perspectives are original insights and strategic frameworks published by Skystone Atlas — written for leaders who are building, deciding, and moving forward — across clinical, scientific, and business disciplines.
Substantive insights for healthcare and life sciences leaders — published when they are ready, not on a schedule.